Medicare program; coverage of epoetin (EPO) used by competent home dialysis patients--HCFA. Final rule.
This final rule adopts as final the interim final rule that provided for Medicare coverage of EPO used by ESRD beneficiaries who dialyze at home and are competent to use the drug without medical or other supervision and established criteria for selection of patients that can be considered "competent" and for monitoring of the patients who are selected. It also makes minor changes in response to public comments on the interim rule. The interim rule was necessary to implement section 4201(d)(1) of the Omnibus Budget Reconciliation Act of 1990 (OBRA '90). The purpose of the amendments is to facilitate use of EPO at home, while ensuring that such use of the drug is safe.
D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D014487:Centers for Medicare and Medicaid Services, U.S.; D004921:Erythropoietin / Q000008:administration & dosage / Q000191:economics*; D006437:Hemodialysis, Home / Q000191:economics* / Q000592:standards; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D007676:Kidney Failure, Chronic / Q000150:complications; D006278:Medicare / Q000191:economics / Q000331:legislation & jurisprudence*; D012646:Self Administration; D014481:United States